Colgate-Palmolive (NYSE:CL) Holdings Cut by Zevin Asset Management LLC

Zevin Asset Management LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 3.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 63,152 shares of the company’s stock after selling 2,400 shares during the period. Colgate-Palmolive comprises approximately 1.4% of Zevin Asset Management LLC’s holdings, making the stock its 24th largest holding. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $4,328,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Capital Financial Planning LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $27,000. Timber Creek Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after acquiring an additional 336 shares in the last quarter. Parisi Gray Wealth Management grew its holdings in shares of Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after acquiring an additional 369 shares in the last quarter. Portfolio Solutions LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $30,000. Finally, WP Advisors LLC bought a new position in shares of Colgate-Palmolive in the 1st quarter valued at about $34,000. Hedge funds and other institutional investors own 74.63% of the company’s stock.

CL traded down $0.55 during trading on Friday, hitting $71.20. 1,941,506 shares of the stock traded hands, compared to its average volume of 3,688,568. Colgate-Palmolive has a twelve month low of $57.41 and a twelve month high of $73.10. The company has a market cap of $61.60 billion, a P/E ratio of 23.97, a P/E/G ratio of 4.69 and a beta of 0.81. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.66 by $0.01. The business had revenue of $3.88 billion during the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The company’s revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.74 earnings per share. On average, analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were issued a dividend of $0.43 per share. The ex-dividend date was Wednesday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. Colgate-Palmolive’s dividend payout ratio is 57.91%.

A number of research firms recently commented on CL. ValuEngine upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, May 13th. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Monday, May 13th. Macquarie lifted their price target on Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a report on Monday, April 29th. Morgan Stanley lifted their price target on Colgate-Palmolive from $62.00 to $68.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Finally, Jefferies Financial Group boosted their price objective on Colgate-Palmolive from $61.00 to $73.00 and gave the stock an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $69.69.

In related news, CEO Ian M. Cook sold 16,000 shares of the business’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $66.72, for a total value of $1,067,520.00. Following the sale, the chief executive officer now owns 1,146,793 shares of the company’s stock, valued at $76,514,028.96. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Ian M. Cook sold 17,750 shares of the business’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $68.61, for a total transaction of $1,217,827.50. Following the completion of the sale, the insider now directly owns 1,111,293 shares in the company, valued at approximately $76,245,812.73. The disclosure for this sale can be found here. Insiders have sold 335,211 shares of company stock valued at $23,724,495 over the last quarter. Company insiders own 1.14% of the company’s stock.

WARNING: “Colgate-Palmolive (NYSE:CL) Holdings Cut by Zevin Asset Management LLC” was posted by Sundance Herald and is owned by of Sundance Herald. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://sundanceherald.com/2019/05/24/zevin-asset-management-llc-sells-2400-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Strangles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply